<br><br><div class="gmail_quote"><br>
From: <a href="mailto:kumargopakm@gmail.com">kumargopakm@gmail.com</a><br>
<br><p class="MsoNormal"><font face="'Times New Roman'" size="4"><span style="font-size:15px"><span style="font-family:arial,sans-serif;font-size:13px;border-collapse:collapse;color:rgb(34,34,34)">Women affected by breast cancer, in alliance with the women's movement<br>
and treatment activists are launching a public campaign in India -<br>with a sign on letter to the Prime Minister - for access to<br>Trastuzumab (Herceptin), the breast cancer drug. Roche is charging<br>breast cancer patients in India between Rs.72,000 (1385 USD) to 92,000<br>
(1730 USD) per dose. The letter requests the Indian PM to take strict<br>action against Roche; to start providing the drug to patients free of<br>cost; and to encourage the development of affordable biosimilar of<br>Trastuzumab.<br>
</span></span></font></p><p class="MsoNormal"><font face="'Times New Roman'" size="4"><span style="font-size:15px"><span style="font-family:arial,sans-serif;font-size:13px;border-collapse:collapse;color:rgb(34,34,34)"><br>
</span></span></font></p><p class="MsoNormal"><font face="'Times New Roman'" size="4"><span style="font-size:15px"><font color="#222222" face="arial, sans-serif" size="3"><span style="border-collapse:collapse;font-size:13px">Those who are interested in signing on on a petition and for more details, please send an email to <br>
<a href="mailto:kumargopakm@gmail.com" style="color:rgb(17,85,204)" target="_blank">kumargopakm@gmail.com</a> (KM. Gopa Kumar).</span></font></span></font></p><br></div><br>